• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Needle-Free Drug Injection Systems and Safety Syringes - Global Strategic Business Report Product Image

Needle-Free Drug Injection Systems and Safety Syringes - Global Strategic Business Report

  • Published: July 2012
  • Region: Global
  • 504 Pages
  • Global Industry Analysts, Inc

This report analyzes the worldwide markets for Needle-Free Drug Injection Systems and Safety Syringes in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets.

The report profiles 93 companies including many key and niche players such as First Principals, Inc., Cambridge Consultants Ltd., Antares Pharma, Inc., Bard Biopsy Systems, Baxter International, Inc., Baxter BioPharma Solutions, Bector, Dickinson, BD Medical, Bioject Medical Technologies, Inc., Covidien Plc, Crossject Ltd., DAntonio Consultants International, Inc., Glide Pharmaceutical Technologies Ltd., Incline Therapeutics, Inc., INJEX Pharma GmbH, Medical International Technologies (Mit Canada), Inc., National Medical Products, Inc., PenJet Corporation, PowderJect Pharmaceuticals Plc, Retractable Technologies, Inc., Safety Syringes, Inc., Smiths Group, Smiths Medical, Terumo Corporation, Unilife Medical Solutions Ltd., Valeritas, Ypsomed Holding AG, and Zogenix, Inc.

Market data and analytics READ MORE >

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
Study Reliability and Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions and Scope of Study I-3
Safety Syringes I-3
Needle-Free Injections I-3

II. Executive Summary

1. INDUSTRY OVERVIEW II-1
A Prelude II-1
Market Overview II-1
Current and Future Analysis II-1
Needlestick Injuries - A Menace in Healthcare Environment II-2
Evolving Drug Delivery Systems II-2
Factors Determining User Choice in Safety Syringes II-2
Factors Enabling Espousal of Safety and Pre-filled Injections II-3
Major Advantages of Needle-Free Injection Systems II-3
Legislations - The Base for Technology Improvements and Demand II-3
Ongoing Research to Further Advance Delivery Systems, Fuel
Market Growth II-4
Future Market to Offer Multiple Drug Delivery Alternatives II-4
Needle-Free Injection Systems Market II-4
Demand for Needle-Free Systems Gathers Pace II-4
Trends toward Needle-Free Injections II-5
Extending Patent Life through Differentiation from
Competitive Generics II-5
Safety and Efficacy - Amongst the Prime Motivating Factors II-5
Patient Involvement II-5
Needle-Free Future Unlikely II-6
Regulations - A Shot on the Arm for Needle-free Market II-6
Safety Syringes Market II-6
Demand for Pre-filled Safety Syringes North-Bound II-6
Pre-filled Syringes - Benefiting All Stakeholders II-7
Markets Crave for Further Advancements in Safety Syringes II-7
Insulin Delivery - A Burgeoning Market for Novel Delivery
Systems II-8
Competitive Landscape II-8
Table 1: Leading Suppliers of Safety Syringes Worldwide
(2011E): Percentage Breakdown of Sales for Becton, Dickinson
and Company, Covidien, Terumo, Retractable and Others
(includes corresponding Graph/Chart) II-8
Other Key Statistics II-8
Table 2: Leading Pharmaceutical Companies in the Pre-Filled
Vaccine Syringes Market (2011): Percentage Breakdown of
Revenues for GSK, Sanofi, Novartis and Others (includes
corresponding Graph/Chart) II-8

Table 3: Leading Pharmaceutical Companies in the Pre-Filled
Hematology Syringes Market (2011): Percentage Breakdown of
Revenues for Roche, Amgen and Others (includes corresponding
Graph/Chart) II-9

Table 4: Leading Pharmaceutical Companies in the Pre-Filled
Anti-Coagulant Syringes Market (2011): Percentage Breakdown
of Revenues for Sanofi, GSK and Others (includes
corresponding Graph/Chart) II-9
Ready-to-Fill Segment Goes Strong II-9
Table 5: Global Ready-to-Fill Syringe Consumption: 2007-2011
(In Billion Units) (includes corresponding Graph/Chart) II-10

Table 6: Leading Pharmaceutical Companies by Pre-filled
Syringe Consumption (2011): Percentage Breakdown of Value
Consumption for Sanofi, GSK, Novartis, Pfizer, Roche and
Others (includes corresponding Graph/Chart) II-10

Table 7: World Sales of Drugs in Pre-filled Syringes by
Therapeutic Class (2011): Percentage Breakdown of Revenues
for Vaccines, Hematology, Multiple Sclerosis,
Anti-inflammatory, Anticoagulants and Others (includes
corresponding Graph/Chart) II-10

2. PRODUCT OVERVIEW II-11
Introduction II-11
Historical Background II-11
Mechanism II-11
Safety Syringe II-12
Pre-Filled Syringe II-12
Oral Vaccines II-12
Nasal Sprays, Suppositories and Eye and Nose Drops II-12
Inhalers II-13
Transdermal II-13
Injected Fine Mist or Powder II-13
Jet Injectors II-13
Iontophoretic Transdermal II-14
Patches II-14
Implants II-14
Microneedles II-14
Material Used for Production II-15
Designing of Needle-free Injection Systems II-15
The Production Process II-15
Manufacturing the Pieces II-16
Assembling and Labeling II-16
Packaging II-16
Quality Control II-16
Safe Medical Devices II-16
Auto-Injectors and Pen Injector II-17
Benefits for Human II-17
Greater Patient Acceptance and Compliance II-17
Enhanced Safety II-17
Improved Effectiveness II-17
Swift Injection Time II-17
Advantages of Using Needle-Free Injectors in Animals II-18
Disease Transmission Reduction II-18
Immunology Improvement II-18
Improvement in Beef Quality II-18
Employee Safety II-18
Needle-free Delivery of Liquids and Solids II-18

3. PRODUCT INTRODUCTIONS II-20
Revolutions Medical Launches New Improved Website II-20
MedPro Safety Products Launches Pre-filled Safety Syringe II-20
MedPro Safety Products Launches Passive Hypodermic Safety Syringe II-20
Greiner Bio-One and MedPro Safety Products Launch PREMIUM
Safety Needle System Tube-Touch II-21
MIT Introduces MED-JET® Products in the Russian Market II-21
Revolutions Medical Develops Pre-filled Auto Retractable
Vacuum Safety Syringes II-21
ALK-Abello Unveils Jext - A New Adrenaline Auto-Injector II-21
Fred Meyer Stores Offers Bioject Medical Technologies'
Biojector® 2000 II-21
Revolutions Medical Introduces New Automatic Retractable
Safety Syringe Designs II-22
Revolutions Medical Unveils 3ml RevVac Safety Syringe II-22
SCHOTT Pharmaceutical Packaging Develops InJentle™ II-22
PharmaJet Develops Needle-Free Jet Injection Technology II-23
Smiths Medical Launches Medfusion® 4000 Syringe Infusion Pump II-23
Teva Pharmaceutical Industries Rolls Out New Tjet™ Needle-Free
Injector System II-24
Occupational and Medical Innovations Rolls Out Auto-
Retractable Safety Syringe II-24
Pharmastandard to Launch Ypsomed's Ypsopen in Russia II-24

4. RECENT INDUSTRY ACTIVITY II-25
Insvet and AcuShot™ Ink Distribution Agreement II-25
Antares Pharma Receives US Patent for Vibex™ Technology II-25
Paketeria Acquires INJEX Pharma II-25
Unilife Commences Sale of Unifill Ready-to-fill Syringes to
Multinational Pharmaceutical Company II-25
Zogenix and DURECT Sign Development and License Agreement II-25
Clinigen Pharma and Zogenix Sign Collaborative Agreement II-26
Bioject Medical Technologies to Supply Intradermal Pen II-26
Revolutions Medical to Manufacture 5 million RevVac 1ml Fixed
Needle Safety Syringe Every Month II-27
Revolutions Medical Receives Clearance from the DLA for the
RevVac Safety Syringe II-27
Revolutions Medical Files Provisional Patent Application for
Vacuum Technology-based Pre-Filled Safety Syringes II-27
Medical International Technology Gains Chinese SFDA
Certification for MED-JET® Products II-27
Revolutions Medical and CeifiT Ink Marketing and Distribution
Agreement II-27
Revolutions Medical and DS WorldMed Ink Marketing and
Distribution Agreement II-28
Revolutions Medical and Wuxi Yushou Medical Appliance Ink
Definitive Manufacturing Agreement II-28
INJEX Pharma and Al Shamali Group Ink an Exclusive Distributor
Contract II-28
INJEX Pharma Inks Exclusive Sales and Marketing Agreement with
GenTech Laboratories for INJEX Needle-Free Syringes II-29
Unilife Bags Supply Contract for Unitract Safety Syringes from
Premier Purchasing Partners II-29
US FDA Grants Two 510(k) Marketing Clearances for PharmaJet's
IM/SC Injection Technology II-29
Zogenix Ends Co-Promotion Agreement with Astellas Pharma for
the SUMAVEL DosePro II-29
Kroger Include PharmaJet Needle-Free Injection Systems in Flu
-Shot Campaign II-30
Valeritas' V-Go™ Disposable Insulin Delivery Medical Device
Obtains CE Mark Approval II-30
Revolutions Medical Receives Patent for Marketing RevVac
Safety Syringe in the Chinese Market II-30
Zogenix and Desitin Obtain Marketing Approval for SUMAVEL DosePro II-30
Smiths Medical to Establish Subsidiary in India II-31
Unilife Commences Unifill Pre-filled Syringe Production II-31
PharmaJet Secures FDA Clearance for Intradermal Needle-Free
Injection Device II-31
Cadence Enters into Agreement for Acquiring Incline Therapeutics II-31
PharmaJet Signs Collaboration Agreement with USAMRIID II-31
Revolution Medical and Santa Monica Pharmaceutica Enter into
Strategic Partnership II-32
Standard Chem and Pharm Enters into Distribution Agreement
with Unilife II-32
Bioject Medical Technologies and MPI Research Enter into Alliance II-32
Revolutions Medical and MIG Sign Manufacturing Agreement II-32
Protectus Medical Devices Inks Agreement with Moll II-33
Unilife Starts Selling Unitract® 1ml Syringes II-33
Inviragen and PharmaJet Obtain NIAID Contract for Developing
Needle-Free Dengue Vaccine II-34
Safety Syringes Selects Polycarbonate Resin of Bayer
MaterialScience II-34
Incline Therapeutics and ALZA Enter into Agreement II-34
Desitin Pharmaceuticals and Zogenix Obtain Marketing
Authorization for SUMAVEL® DosePro™ from Danish Medicines
Agency II-35
Antares Pharma Announces Advancements in Vibex™ Auto-Injectors II-35
TOLMAR Holding Acquires QLT USA II-35
SquareOne Medical Completes Reverse Merger into E-18 II-36
West Pharmaceutical Services Takes Over Assets of Plastef
Investissements II-36
Revolutions Medical Obtains FDA Approval for Marketing Rev Vac
Safety Syringe II-36
Bioject Medical Technologies and Ferring Pharmaceuticals
Extend Supply Agreement II-36
Med-Pharmex and AcuShotTM Ink Exclusive Distribution Agreement II-37
Revolutions Medical and Libra International Ink Distribution
Agreement II-37
Cardinal Health and OMI Ink Exclusive Distribution Agreement II-37
Astellas Pharma and Zogenix Ink Agreement to Co-Promote
Sumavel DosePro II-37
Unilife and Sanofi Winthrop Industrie Ink Industrialization
Agreement II-38
Bioject Medical Technologies Receives FDA 510(k) Clearance for
ZetajetTM II-38
PharmaJet Collaborates with PATH II-38
Lipoxen and Glide Pharma Ink Agreement II-39
Ypsomed Holding and Gamma Medica Enter into Distribution
Agreement II-39
Zogenix Receives FDA Approval for SUMAVEL® DoseProTM II-39

5. FOCUS ON SELECT KEY PLAYERS II-40
First Principals, Inc. (US) II-40
Cambridge Consultants Ltd. (UK) II-40
Antares Pharma, Inc. (US) II-40
Bard Biopsy Systems (US) II-40
Baxter International, Inc. (US) II-41
Baxter BioPharma Solutions (US) II-41
Bector, Dickinson (US) II-41
BD Medical II-41
Bioject Medical Technologies, Inc. (US) II-41
Covidien Plc (Ireland) II-42
Crossject Ltd. (France) II-42
DAntonio Consultants International, Inc. (US) II-42
Glide Pharmaceutical Technologies Ltd. (UK) II-42
Incline Therapeutics, Inc. (US) II-43
INJEX Pharma GmbH (Germany) II-43
Medical International Technologies (Mit Canada), Inc. (Canada) II-43
National Medical Products, Inc. (US) II-43
PenJet Corporation II-43
PowderJect Pharmaceuticals Plc (UK) II-44
Retractable Technologies, Inc. (US) II-44
Safety Syringes, Inc. (US) II-44
Smiths Group (UK) II-44
Smiths Medical (US) II-44
Terumo Corporation (Japan) II-45
Unilife Medical Solutions Ltd. (US) II-45
Valeritas (US) II-45
Ypsomed Holding AG (Germany) II-46
Zogenix, Inc. (US) II-46

6. GLOBAL MARKET PERSPECTIVE II-47
Table 8: World Recent Past, Current and Future Analysis for
Needle-Free Drug Injection Systems and Safety Syringes by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2010 through 2018 (includes corresponding Graph/Chart) II-47

Table 9: World Historic Review for Needle-Free Drug Injection
Systems and Safety Syringes by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), and Rest of
World Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) II-48

Table 10: World 15-Year Perspective for Needle-Free Drug
Injection Systems and Safety Syringes by Geographic Region -
Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), and Rest of World
Markets for Years 2004, 2011 and 2018 (includes corresponding
Graph/Chart) II-49

III. MARKET

1. THE UNITED STATES III-1
A.Market Analysis III-1
Current and Future Analysis III-1
The Torch Bearers III-1
Leading Players Operating in the Largest Individual Market III-1
Product Launches III-1
Strategic Corporate Developments III-4
Select Key Players III-15
B.Market Analytics III-20
Table 11: US Recent Past, Current and Future Analysis for
Needle-Free Drug Injection Systems and Safety Syringes
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-20

Table 12: US Historic Review for Needle-Free Drug Injection
Systems and Safety Syringes Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) III-21

2. CANADA III-22
A.Market Analysis III-22
Current and Future Analysis III-22
Product Launch III-22
Medical International Technologies (Mit Canada), Inc. - A
Leading Canadian Player III-23
B.Market Analytics III-23
Table 13: Canadian Recent Past, Current and Future Analysis
for Needle-Free Drug Injection Systems and Safety Syringes
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-23

Table 14: Canadian Historic Review for Needle-Free Drug
Injection Systems and Safety Syringes Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-24

3. JAPAN III-25
A.Market Analysis III-25
Current and Future Analysis III-25
Terumo Corporation - A Leading Japanese Player III-25
B.Market Analytics III-26
Table 15: Japanese Recent Past, Current and Future Analysis
for Needle-Free Drug Injection Systems and Safety Syringes
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-26

Table 16: Japanese Historic Review for Needle-Free Drug
Injection Systems and Safety Syringes Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-27

4. EUROPE III-28
A.Market Analysis III-28
Current and Future Analysis III-28
Region-Wide Laws on Safety Syringes on the Cards III-28
B.Market Analytics III-29
Table 17: European Recent Past, Current and Future Analysis
for Needle-Free Drug Injection Systems and Safety Syringes
by Geographic Region - France, Germany, Italy, UK, Spain,
Russia, and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2010
through 2018 (includes corresponding Graph/Chart) III-29

Table 18: European Historic Review for Needle-Free Drug
Injection Systems and Safety Syringes by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2004 through 2009 (includes
corresponding Graph/Chart) III-30

Table 19: European 15-Year Perspective for Needle-Free Drug
Injection Systems and Safety Syringes by Geographic Region -
Percentage Breakdown of Dollar Sales for France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets for
Years 2004, 2011 and 2018 (includes corresponding
Graph/Chart) III-31

4a. FRANCE III-32
A.Market Analysis III-32
Current and Future Analysis III-32
Strategic Corporate Developments III-32
Crossject Ltd. - A French Player III-32
B.Market Analytics III-33
Table 20: French Recent Past, Current and Future Analysis
for Needle-Free Drug Injection Systems and Safety Syringes
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-33

Table 21: French Historic Review for Needle-Free Drug
Injection Systems and Safety Syringes Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-34

4b. GERMANY III-35
A.Market Analysis III-35
Current and Future Analysis III-35
Product Launch III-35
Strategic Corporate Developments III-35
Select Key Players III-36
B.Market Analytics III-37
Table 22: German Recent Past, Current and Future Analysis
for Needle-Free Drug Injection Systems and Safety Syringes
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-37

Table 23: German Historic Review for Needle-Free Drug
Injection Systems and Safety Syringes Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-38

4c. ITALY III-39
Market Analysis III-39
Table 24: Italian Recent Past, Current and Future Analysis
for Needle-Free Drug Injection Systems and Safety Syringes
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-39

Table 25: Italian Historic Review for Needle-Free Drug
Injection Systems and Safety Syringes Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-40

4d. THE UNITED KINGDOM III-41
A.Market Analysis III-41
Current and Future Analysis III-41
Strategic Corporate Developments III-41
Select Key Players III-42
B.Market Analytics III-43
Table 26: UK Recent Past, Current and Future Analysis for
Needle-Free Drug Injection Systems and Safety Syringes
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-43

Table 27: UK Historic Review for Needle-Free Drug Injection
Systems and Safety Syringes Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2004 through
2009 (includes corresponding Graph/Chart) III-44

4e. SPAIN III-45
A.Market Analysis III-45
Current and Future Analysis III-45
Strategic Corporate Development III-45
B.Market Analytics III-46
Table 28: Spanish Recent Past, Current and Future Analysis
for Needle-Free Drug Injection Systems and Safety Syringes
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-46

Table 29: Spanish Historic Review for Needle-Free Drug
Injection Systems and Safety Syringes Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-47

4f. RUSSIA III-48
A.Market Analysis III-48
Current and Future Analysis III-48
Product Launches III-48
B.Market Analytics III-49
Table 30: Russian Recent Past, Current and Future Analysis
for Needle-Free Drug Injection Systems and Safety Syringes
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2010 through 2018 (includes corresponding
Graph/Chart) III-49

Table 31: Russian Historic Review for Needle-Free Drug
Injection Systems and Safety Syringes Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-50

4g. REST OF EUROPE III-51
A.Market Analysis III-51
Current and Future Analysis III-51
Product Launch III-51
Strategic Corporate Developments III-51
Covidien Plc - An Irish Player III-52
B.Market Analytics III-53
Table 32: Rest of Europe Recent Past, Current and Future
Analysis for Needle-Free Drug Injection Systems and Safety
Syringes Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-53

Table 33: Rest of Europe Historic Review for Needle-Free
Drug Injection Systems and Safety Syringes Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2004 through 2009 (includes corresponding Graph/Chart) III-54

5. ASIA-PACIFIC III-55
A.Market Analysis III-55
Current and Future Analysis III-55
Demand for Safety Syringes in Asia Yet to Take Off III-55
Safety Syringe Market in India Sets Off III-55
Product Launch III-55
Strategic Corporate Developments III-56
B.Market Analytics III-57
Table 34: Asia-Pacific Recent Past, Current and Future
Analysis for Needle-Free Drug Injection Systems and Safety
Syringes Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-57

Table 35: Asia-Pacific Historic Review for Needle-Free Drug
Injection Systems and Safety Syringes Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-58

6. REST OF WORLD III-59
A.Market Analysis III-59
Current and Future Analysis III-59
Strategic Corporate Developments III-59
B.Market Analytics III-60
Table 36: Rest of World Recent Past, Current and Future
Analysis for Needle-Free Drug Injection Systems and Safety
Syringes Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2010 through 2018 (includes
corresponding Graph/Chart) III-60

Table 37: Rest of World Historic Review for Needle-Free Drug
Injection Systems and Safety Syringes Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2004
through 2009 (includes corresponding Graph/Chart) III-61

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 93 (including Divisions/Subsidiaries - 104)

The United States (46)
Canada (7)
Japan (2)
Europe (21)
- France (5)
- Germany (5)
- The United Kingdom (5)
- Rest of Europe (6)
Asia-Pacific (Excluding Japan) (27)
Middle-East (1)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos